TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: LCI2.5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Scond*Vt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: health distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CV death/HHF
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of night time with PtcCO2 > 45 mm Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ineffective efforts (events/hour)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Efficacy at day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative hypoparathyroidism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Amplitude of P50 waves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Amplitude of N95 waves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peak time of P50 wave
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Work-life balance
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: P0.1 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Efficacy of infliximab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of infliximab
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity of infliximab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time interval for analgesic requirement after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sexual function and activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary and bowel function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: modified Eczema Area and Severity Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paresthesia intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Boston questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Confidence in self-care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Satisfaction in the parenting role
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Headache pain freedom at 2 hours post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Most bothersome symptom freedom at 2 hours post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency and severity of adverse oral impacts
Endpoint domain: Adverse events/effects
Primary endpoint: denture pain
Endpoint domain: Adverse events/effects
Primary endpoint: oral health-related quality of life (OHRQoL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time taken to tolerate LRD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in SAT mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in VAT mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quick-Disabilities of the Arm, Shoulder and Hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobility dimension of European Quality of Life-Five Dimensions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Surgical field quality score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: afterpain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in basic psychological needs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Virologic suppression (VL <50 c/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with BCVA gain ≥ 15 letters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in CMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in CAPS-5 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of type 1 or 2 myocardial infarction (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of all-cause death after type 1 MI
Endpoint domain: Mortality/survival
Primary endpoint: Dialysis initiation after type 1 MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Annualized severe exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder recurrence
Endpoint domain: Mortality/survival
Primary endpoint: incremental QALY
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: MRI evidence of ACL healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KOOS-QOL at 2-year follow-up
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mammography screening uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generativity document analysis themes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: uptake of evidence-based management of acute conditions
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: UAER percentage change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Validity of step counter (FC3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment time of SAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of any IUD at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete expulsion or removal of IUD
Endpoint domain: Adverse events/effects
Primary endpoint: C-index of the integrated nomogram
Endpoint domain: Mortality/survival
Primary endpoint: ANC reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Decrease in negative emotion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increase in BOLD percentage signal change in cognitive and attention-regulation regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back muscle CSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: efavirenz concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: serum iron levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: transferrin saturation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Self-rated ability to interact with patients about quitting smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of oncogenic HPVs (HPV16/18)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: VIA-positivity rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Urge to use opiates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: M. tuberculosis-specific CD4+ cytokine responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Success rates of intercostal nerve injections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of intercostal nerve staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preference for SC over IV
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction with SC injection
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Median patient treatment room time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher abstinence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower stress about finances
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduced frequency of being unable to afford activities
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Incidence of blood oxygen desaturation ≤ 85%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of time spent with SpO2 in the acceptable range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: handgrip strength change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10 Meter Walk Test (10 MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stabilometric assessment (length of CoP and sway area)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eligibility for the trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of participants with resolved acute vulvovaginal candidiasis infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with ≥1 culture-verified acute vulvovaginal candidiasis episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Past-month binge drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with relevant ADA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CPM-magnitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance to FMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desire to continue FMT therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: endurance time increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' preferences for injection frequency
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Resting Energy Expenditure (REE) values calculated by Thumb formula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resting Energy Expenditure (REE) values calculated by Third Military Medical University formula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resting Energy Expenditure (REE) values calculated by Hangang formula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-year disease-free survival (2y-DFS)
Endpoint domain: Mortality/survival
Primary endpoint: incidence of grade ≥ 2 facial acneiform rash
Endpoint domain: Adverse events/effects
Primary endpoint: Time to screening completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women delivering vaginally
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Correct answer rate for pleural friction rubs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: CA-AKI incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of stop breastfeeding due to recurrence of mastitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rhinosinusitis Disability Index (RSDI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nasal polyp grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rehospitalization for MI or heart failure
Endpoint domain: Mortality/survival
Primary endpoint: bioequivalence of LZM003 to reference drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-Year Overall Survival (OS)
Endpoint domain: Mortality/survival
Primary endpoint: CPTSD prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comorbidity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Current PrEP use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tidal volume improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Oswestry Disability Index, Visual Analog Score leg and back, and Zurich Claudication Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: therapeutic efficacy evaluation of hematopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: masculinization score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG coordinates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Academic motivation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: serum levels of IL-4, IL-10 and TGF-β
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in mean density of hairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in mean caliber
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients improved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HPV vaccination series completion by 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: At least one HPV vaccine received by 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cerebral events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: renal events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean SDS changes from pretraining to 16 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Role-play-based diagnoses accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient diagnoses accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children experienced less moderate-to-severe pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-Reactive Protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: APACHE II Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidences of EGFRIs induced acneiform rash
Endpoint domain: Adverse events/effects
Primary endpoint: Severities of EGFRIs induced acneiform rash
Endpoint domain: Adverse events/effects
Primary endpoint: Recovery time from pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of death or disability at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: Perception of verticality (PV) tilts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: night sleep period
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: daytime wakefulness
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: vocal emotional prosody perception scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adolescent asset building
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: school attendance
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: prosocial behavior
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Mean number of hypoxic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Length of stay in the hospital and ICU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: MAINTAIN score for identifying dysfunctional patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EC‐SOD activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: noradrenaline levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: time-dependent hazard ratio
Endpoint domain: Mortality/survival
Primary endpoint: Composite outcome of mechanical ventilation or death by day 28
Endpoint domain: Mortality/survival
Primary endpoint: Time to hospital discharge within 28 days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Successful fitting with the Gellhorn pessary
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biomarkers of liver injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intraindividual variability in symptoms predicting sudden gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with foot appearance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvement of local joint inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: emotion management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: salivary Aβ‐42 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FA decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedure-related pain and anxiety scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds ratio of CAD per 1-standard deviation increase in genetically predicted BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Health knowledge mastery of CHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life quality score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CWRT time improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of added sugars content
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intent to purchase products
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Intraoperative fluoroscopy frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in lesion area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in color of white spot lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean weight improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean MUAC improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived pain at deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implementation of population-based OUD screening
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: caregiver wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: expressed emotion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Urinary metabolites predict CYP2D6 genotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of care and dying in the last month of life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of decayed teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of filled teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of decayed tooth surfaces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maintenance of health behaviour changes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in incidence of tinnitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with MHP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: percent predicted FEV1 change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Recruitment and randomization of patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Supplementation protocol violation rate
Endpoint domain: Adverse events/effects
Primary endpoint: 28-day follow-up rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention